From the Congenital Heart Futures Act to the Present: An Update on CDC’s Congenital Heart Activities

Since the passage of the Congenital Heart Futures Act in 2010 and, subsequently, the Congenital Heart Futures Reauthorization Act of 2017, the Centers for Disease Control and Prevention (CDC) has enhanced and expanded congenital heart defect (CHD) research, tracking, and awareness activities.

Join Dr. Jennita Reefhuis, chief of CDC’s Birth Defects Monitoring and Research Branch, as she describes CDC’s CHD activities and progress being made through the funding authorized by the Congenital Heart Futures Reauthorization Act.